Soligenix, SELLAS Life Sciences Group, AcelRx, WeedMD, Arcadia Biosciences and Security Devices International are also moving in the trading session
Showing 25 of 5959
For all the hype of a relatively new social media platform coming to market, never have views been more divided than over the now-you-see-it-now-you-don’t Snapchat. And that doesn’t bode too well for a company whose IPO is this week
The tech sector is going through a topsy-turvy period of reform right now
Investors were treated to another stock rotation opportunity – read surprise – on Wednesday when US President-elect Donald Trump struck a conciliatory tone with technology company chiefs in a New York meeting
Amazon is no stranger to controversy, be that in its fiscal arrangements around the world or putting high street stores out of business as it cannibalises retailing online
Tech stocks have had a rough month since the election of Donald Trump to be next President. But some commentators think there is a silver lining
After Thanksgiving Day investors may be contemplating whether ditching high dividend payers like Real Estate Investment Trust (REIT) or whether to hold on
Volumes will be lighter on this side of the pond as US investors celebrate the Thanksgiving holiday. The corporate calendar is understandably on the light side, but it is not empty.
Watching the way Wall Street index tickers have raced to fresh record highs on both Monday and Tuesday, investors might be forgiven for thinking that pretty much any stock is doing well on the so-called “Trump Trade”, coined in the wake of Donald Trump’s presidential election victory earlier this month
Two US tech giants made savvy life-saving decisions on Monday. Anti-virus software group Symantec bought into a company that gives it better exposure to mobile devices, while Facebook decided to expand outside of the United States with 500 new hires in the UK
Kingfisher Plc, Homeserve PLC, Rotork PLC and Babcock International Group PLC are all in Tuesday's agenda
Credit markets deliver their verdict on US interest rates. Without a shred of a doubt US interest rates are going up on December 14. But what happens if they are wrong?
It may seem the phrase manufactured misfortune was invented for Valeant Pharmaceuticals Intl
In July, the group said it was monitoring the Brexit situation as movements in gross domestic product were drivers for volumes of letter and business parcels
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
Fed-up with reading about self-publicising billionaires? I've got some bad news for you ...
After a week of haemorrhaging, the tech sector looks like it might be turning a corner – but only as it offers an olive branch to the US President-elect Donald Trump
Another day, another house builder reporting on living the life of Riley in this prolonged low interest rate environment
If the market had a vote the next US interest rate hike will be on December 14. Markets on Monday priced in a 92% chance of a rate hike, up by 10 percentage points since it was confirmed that Donald Trump had won the presidential election last Wednesday
Angus Energy beefs up its share price; Trump looking to back out of climate control accord; dementia overtakes heart disease as main killer in UK
While the S&P 500 index may have slipped on Friday, and other tech stocks are licking wounds from Donald Trump’s election victory, one stock was bravely leading the risers - and done so in spectacular style: PC graphics maker NVIDIA
Miners provided the day's highlights, but they weren't alone.
Elsewhere, Akers Biosciences has secured a European patent; CloudTag makes progress on recent order; takeover sharks are circling ServicePower; plus much more…
Market analysts have been quick to offer their insights and experiences into the mix of commentary over what the future holds now that we are heading for a Donald Trump administration in January
AstraZeneca, Vedanta, Halfords, and SuperGroup were among those in Thursday's diary.